Blood Cancer

Clokeran Chlorambucil 2 mg Tablet

Clokeran (Chlorambucil 2 mg Tablet) is a prescription medication used in the treatment of certain types of cancer, including chronic lymphocytic leukemia (CLL), Hodgkin's disease, and certain types of lymphoma. Chlorambucil belongs to a class of medications known as alkylating agents, which work by interfering with the DNA of cancer cells, ultimately inhibiting their growth and spread.

Indications:

Clokeran is indicated for the treatment of:

• Chronic lymphocytic leukemia (CLL)
• Hodgkin's disease
• Non-Hodgkin's lymphoma

How to Use:

• Take Clokeran exactly as prescribed by your healthcare provider.
• Swallow the tablet whole with a full glass of water.
• Do not crush, chew, or break the tablet unless directed otherwise by your doctor or pharmacist.
• Follow your doctor's instructions regarding dosage and duration of treatment.

Side Effects:

Common side effects of Clokeran may include:

• Nausea and vomiting
• Diarrhea
• Loss of appetite
• Hair loss
• Weakness or fatigue
• Increased risk of infection due to decreased white blood cell count

Precautions:

• Inform your healthcare provider about any existing medical conditions and medications you are taking.
• Regular blood tests may be required to monitor blood cell counts and liver function during treatment.
• Use effective contraception to avoid pregnancy while taking Clokeran, as it may harm an unborn baby.
• Clokeran is not recommended for use in breastfeeding women.

Storage:

• Store Clokeran tablets at room temperature between 20°C to 25°C (68°F to 77°F).
• Keep the tablets in their original container, tightly closed and protected from moisture and light.
• Keep out of reach of children.

Disclaimer:

This product description is provided for informational purposes only and does not constitute medical advice. Always consult with a healthcare professional before starting any new medication.

₱3

Gilternib Gilteritinib 40 mg Tablets

Gilternib (Gilteritinib 40 mg Tablets) is a potent, selective inhibitor of FLT3, a receptor tyrosine kinase frequently mutated in acute myeloid leukemia (AML). It is specifically indicated for the treatment of adult patients with relapsed or refractory AML with a FLT3 mutation, as detected by an FDA-approved test. By inhibiting the FLT3 protein, Gilteritinib helps to prevent the growth and spread of cancer cells. Our super specialty pharmacy provides high-quality Gilternib with personalized treatment plans and expert support to ensure optimal care for AML patients. Trust us for comprehensive and effective cancer care tailored to your specific needs.

₱1

Azarest Azacitidine 300 mg Tablet

Azarest Azacitidine 300 mg Tablet is an effective antineoplastic agent used primarily in the treatment of myelodysplastic syndromes (MDS), a group of disorders caused by poorly formed or dysfunctional blood cells. Azacitidine works by inhibiting DNA methylation, which can help restore normal function to bone marrow and improve blood cell production. It can also be used to treat certain types of leukemia, including acute myeloid leukemia (AML). Our super specialty pharmacy provides high-quality Azarest with personalized treatment plans and expert support to ensure optimal care for patients with MDS and leukemia. Trust us for comprehensive and effective cancer care tailored to your needs.

₱25,000 ₱24,750

Acabrunat Acalabrutinib 100mg Capsules

Experience cutting-edge treatment for blood cancers with Acabrunat Acalabrutinib 100mg Capsules. Each capsule contains 100mg of acalabrutinib, a potent inhibitor targeting cancerous B-cells' growth and survival. Harnessing the power of science, Acabrunat offers hope for patients battling Mantle Cell Lymphoma (MCL) and Chronic Lymphocytic Leukemia (CLL).

Benefits:

• Targeted Therapy: Acalabrutinib selectively inhibits Bruton tyrosine kinase (BTK), halting cancer cell proliferation while sparing healthy cells.
• Enhanced Efficacy: By blocking BTK signaling pathways, Acabrunat promotes apoptosis, delivering potent anti-cancer effects.
• Improved Quality of Life: With Acabrunat, patients can experience reduced symptoms and enhanced overall well-being.

Dosage and Administration: Take one Acabrunat Acalabrutinib 100mg Capsule orally, once daily, or as directed by your healthcare professional. Swallow the capsule whole with a glass of water, with or without food.

Precautions:

• Follow your healthcare provider's instructions strictly for optimal treatment outcomes.
• Inform your doctor about all medications, supplements, and medical conditions before starting Acabrunat.
• Regular check-ups and monitoring are essential during treatment to assess response and manage potential side effects.

Side Effects: Common side effects may include:

• Nausea
• Diarrhea
• Headache
• Fatigue
• Respiratory infections

₱80,000 ₱74,250

MabAll Rituximab 500mg Vail

MabAll Rituximab 500mg Vial is a powerful medication designed to target specific cells in the body involved in the immune response. Each vial contains 500mg of rituximab, a monoclonal antibody that selectively targets CD20-positive B-cells, which are often implicated in certain types of cancers and autoimmune diseases.

Mode of Action: Rituximab, the active ingredient in MabAll Rituximab 500mg Vial, works by binding to CD20 antigen present on the surface of B-cells. This binding triggers various immune mechanisms, including antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity, leading to the destruction of targeted B-cells. By depleting these abnormal B-cells, rituximab helps modulate the immune response and combat diseases.

Indications: MabAll Rituximab 500mg Vial is indicated for the treatment of:

• Non-Hodgkin's Lymphoma
• Chronic Lymphocytic Leukemia
• Rheumatoid Arthritis
• Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
• Microscopic Polyangiitis

Dosage and Administration: The recommended dosage of MabAll Rituximab 500mg Vial varies depending on the specific condition being treated, the patient's weight, and other factors. It is typically administered intravenously by a healthcare professional over a specified period. Dosage and administration should be tailored to the individual patient's needs and medical history.

Precautions:

• Prior to initiating treatment with MabAll Rituximab 500mg Vial, patients should undergo thorough medical evaluation, including screening for hepatitis B virus (HBV) infection.
• Close monitoring for signs of infusion reactions, infections, and other adverse effects is essential during and after rituximab therapy.
• Patients should receive appropriate premedication to reduce the risk of infusion-related reactions.
• Rituximab should be used with caution in patients with a history of cardiac or pulmonary conditions.

Side Effects: Common side effects associated with MabAll Rituximab 500mg Vial may include:

• Infusion reactions (fever, chills, nausea, headache, rash)
• Fatigue
• Infections (upper respiratory tract infections, urinary tract infections)
• Low white blood cell count (neutropenia)
• Low platelet count (thrombocytopenia)
• Hypertension (high blood pressure)

₱18,000 ₱15,000